Navigation Links
Akron researcher awarded NIH grant for advancing 3-D tumor models for anticancer drug testing

The National Institutes of Health is supporting the work of a University of Akron researcher who may hold the key to improving the effectiveness of cancer treatments. The agency has awarded UA's Hossein Tavana a two-year, $511,000 grant to fund his ongoing efforts to improve the testing and effectiveness of anticancer drugs.

Tavana, an assistant professor of biomedical engineering in the College of Engineering, has developed a method to generate 3-D cultures of cancer cells (spheroids) that better model tumors in the body. These improved models have the potential to dramatically improve the screening and discovery of effective chemotherapeutics, Tavana says.

In support of this novel and promising technology, the NIH awarded Tavana its R21 grant, which is defined by the NIH as a developmental research grant intended to support "exploratory, novel studies that break new ground or extend previous discoveries toward new directions or applications."

Drug testing on 2-D cultures of cancer cells, in which thin layers of cells are treated on a flat dish, does not adequately predict how the drugs will behave in the 3-D environment of the body, Tavana says.

Three-dimensional cultures, on the other hand, in which cancer cells aggregate into spherical clusters, better mimic tumors, allowing for more efficient and cost-effective drug screening and discovery, he adds.

This in turn allows researchers to determine which drugs will best treat particular forms of cancer, eliminating the need to treat patients with a battery of drugs in the hope of finding something that works, Tavana explains.

"Rather than throwing a bunch of different drugs into a patient's body, we can say, 'This particular patient, based on this test, will most likely benefit from this chemo drug.'"

Whereas other labs are generating 3-D cancer cell spheroids, or aggregates, one at a time, Hossein's unique method allows him to generate 384 spheroids "robotically and in a single step," drastically expediting drug testing.

The robot, equipped with rows of pipettes, dispenses cancer cells into 384 small wells, or miniature test tubes, each of which contains a liquid that provides nutrients to the immersed cells, allowing them to aggregate as they would in the body, resulting in 384 physiologic tumor models.

Tavana and his research team are currently testing cell lines cells that have been made immortal so they can be reused over and over of triple negative breast cancer cells and skin cancer. Next year they plan to use primary, patient-derived cells, which will allow them to test drugs under more realistic conditions.


Contact: Denise Henry
University of Akron

Related medicine news :

1. Akron General President & CEO deemed 2013 Wellness Warrior
2. Akron General Health System, Kent State University Form Health and Wellness Research Collaborative
3. CottageCare® Akron Now Offers Patio Cleaning
4. Akron researchers devise Rx for ailing wellness programs
5. UTSA researchers develop prototype football kicking simulator
6. CWRU researchers aim nanotechnology at micrometastases
7. Risk of osteoporosis drugs side effects not significant, Loyola researchers find
8. New look at old test may provide earlier detection of meningitis, MU researchers find
9. MUHC researchers identify biomarkers that could leadto early diagnosis of colorectal cancer
10. Unpublished trial data violates an ethical obligation to study participants, say researchers
11. Einstein researchers lead panels at NIH Aging and Chronic Disease Symposium on Geroscience
Post Your Comments:
Related Image:
Akron researcher awarded NIH grant for advancing 3-D tumor models for anticancer drug testing
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the organization will waive paid entry and parking fees at several of their ... Monument Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. ...
(Date:11/24/2015)... ... November 24, 2015 , ... Cancer patients, survivors, caregivers, ... at a live taping of the next CURE Connections® video series ... Cancers 2015 Symposium at Georgetown University Hotel & Conference Center in Washington, D.C. ...
(Date:11/24/2015)... ... 2015 , ... With Thanksgiving right around the corner, holiday travel season is ... your family and vehicle. , According to the National Highway Traffic Safety Administration, 301 ... sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester ... University President Carl S. Cleveland III on October 16. , “Katie is very ...
(Date:11/24/2015)... ... 24, 2015 , ... Bibliomotion is thrilled to announce the launch ... and Diversity by Nancy M. Schlichting, Chief Executive Officer of Henry Ford ... address the needs of patients and their families, shaped my desire to improve the ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Avery Biomedical Devices (ABD), manufacturer of the ... appointment of Anders Jonzon , MD; Ph.D. as ... Dr. Jonzon is a Physiologist and consultant ... University, Uppsala and Children,s Hospital, Karolinska, Stockholm, ... at the Cardiovascular Institute (UCSF). His research has covered ...
(Date:11/24/2015)... BERN, Switzerland , November 24, 2015 ... Engineering Research of the University of Bern ... and Clinical Nutrition of the Bern University Hospital "Inselspital" ... collaboration to develop a novel generation artificial pancreas. Combining ... of insulin for diabetic patients with the unequalled accuracy ...
(Date:11/24/2015)... 24, 2015 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced ... Clinical Services, Education and Human Resources will be presenting in ... Drugs: Health Plan Strategies for a Dynamic Market" on Dec. ... , a consultant with the Cambridge Advisory Group, where she ... The webinar will discuss the rapid growth of ...
Breaking Medicine Technology: